Predicción de la inmunogenicidad de la proteína del SARS-CoV-2 responsable de la infección COVID-19 en humanos

Predicción de la inmunogenicidad de la proteína del SARS-CoV-2 responsable de la infección COVID-19 en humanos

<p><strong>Fundamento</strong>: las características estructurales y funcionales de la glicoproteína S del virus SARS-CoV-2 la convierten en un antígeno relevante y una diana deseable para el desarrollo de vacunas y fármacos, pues su bloqueo o neutralización impediría el ciclo infec...

Full description

Bibliographic Details
Main Author:	Orlando Rafael Serrano-Barrera
Format:	Article
Language:	Spanish
Published:	Universidad de Ciencias Médicas de Las Tunas 2020-05-01
Series:	Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta
Subjects:	immunogenicity, vaccine severe acute respiratory syndrome sars virus coronavirus infections sialyltransferases vaccines
Online Access:	http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2270

Similar Items

Seguridad e inmunogenicidad en ensayos clínicos de vacunas para Dengue
by: Janeth Catalina Reyes Castaño, et al.

Evaluación de la inmunogenicidad de una vacuna recombinante antivirus hepatitis B en mujeres adultas sanas, Santafé de Bogotá, D.C., julio 1997 - noviembre 1998
by: María T. Herrera Mendoza, et al.
Published: (1999-06-01)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
by: Hu Li, et al.
Published: (2022-10-01)

Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
by: Mineaki Kitamura, et al.
Published: (2022-04-01)

Inmunogenicidad de proteínas recombinantes comparada con el empleo de herramientas bioinformáticas
by: Orlando R Serrano Barrera

Inmunogenicidad y capacidad protectora en hamsters de vacunas antileptospirósicas monovalentes de células enteras del serogrupo Ballum Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters
by: A. González, et al.
Published: (2005-12-01)

Inmunogenicidad de la proteína recombinante ASP1R de ancylostoma caninum en un modelo murino.
by: Maria Giraldo G, et al.
Published: (2009-05-01)

Development of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-COV-2) Vaccines
by: Kenneth Ogar Inaku, et al.
Published: (2022-01-01)

Development Across the World on Vaccines for COVID-19: A Primer for Primary Care Physicians
by: Rahulkumar Jiteshbhai Amrutiya, et al.
Published: (2021-03-01)

Perception and acceptance of Coronavirus Disease-2019 vaccines among doctors
by: Arun Kumar Yadav, et al.
Published: (2021-01-01)

New variants of SARS-CoV-2, vaccine immune response and the Brazilian reality
by: Marileia Chaves Andrade, et al.
Published: (2021-12-01)

Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
by: Yan Wu, et al.
Published: (2022-12-01)

SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges
by: Balram Ji Omar, et al.
Published: (2022-05-01)

Inmunogenicidad de la vacuna recombinante cubana contra la hepatitis B en trabajadores de la salud peruanos
by: Eduardo Zumaeta Villena, et al.
Published: (2000-04-01)

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults
by: Patrick Yassini, et al.
Published: (2023-01-01)

Efficacy and safety of potential vaccine candidates against coronavirus disease 2019: A systematic review
by: Subodh Kumar, et al.
Published: (2021-01-01)

A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of Age
by: Xin Cheng, et al.
Published: (2023-05-01)

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
by: Ramachandran Vignesh, et al.
Published: (2020-09-01)

Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives
by: Ser John Lynon P. Perez, et al.
Published: (2021-09-01)

Antibody Response following Exposure to SARS-CoV-2: Is It a Reliable Marker of Immunity?
by: Mona Dhakal, et al.
Published: (2022-04-01)

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
by: Yuling Han, et al.
Published: (2022-05-01)

Rise in Levels of Anti-SARS CoV-2 Immunoglubulin G by Covishield Vaccine- A Cohort Study in Rural Medical College, West Bengal, India
by: Jayanta Kumar Rout, et al.
Published: (2022-01-01)

RELACIÓN ESTRUCTURA-INMUNOGENICIDAD DE PROTEÍNAS NATURALES
by: Adela Rodríguez-Romero, et al.
Published: (2010-01-01)

The latent period of coronavirus disease 2019 with SARS‐CoV‐2 B.1.617.2 Delta variant of concern in the postvaccination era
by: Tao Ma, et al.
Published: (2022-07-01)

Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
by: Kei Nakashima, et al.
Published: (2022-11-01)

Immunogenicity Characterization of COVID-19 Vaccines: A Systematic Review and Meta-analysis
by: Zanair Soares Vasconcelos, et al.
Published: (2023-01-01)

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets
by: Sergio C. Oliveira, et al.
Published: (2020-10-01)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
by: Mei-Yue Wang, et al.
Published: (2020-11-01)

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
by: Antonios O. Aliprantis, et al.
Published: (2021-05-01)

Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review
by: Ranim Al Saoud, et al.
Published: (2023-09-01)

SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus
by: Laila Elmancy, et al.
Published: (2022-12-01)

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
by: Nicole V. Tolan, et al.
Published: (2022-04-01)

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
by: Daniel Kwakye Nomah, et al.
Published: (2022-08-01)

SARS-CoV-2 Antibody Response in Patients with Co-morbidities in Kashmir’s Ethnic Population: An Observational Cohort Study
by: Aaliya Mohi-Ud-Din Azad, et al.
Published: (2022-09-01)

The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review
by: Anthony M. Kyriakopoulos, et al.
Published: (2020-09-01)

Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review
by: Caroline Amélia Gonçalves, et al.
Published: (2024-02-01)

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy
by: Panagiotis T. Diamantopoulos, et al.
Published: (2022-08-01)

Human papillomavirus vaccine: An update on recent developments and review of real world data on efficacy
by: Shalini Rajaram, et al.
Published: (2023-01-01)

Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
by: Monika Bociąga-Jasik, et al.
Published: (2023-04-01)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022-11-01)